Phase II trial as new chemotherapy regimen for bevacizumab (Bev) in combination with XELOX in unresectable colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Jan 2019
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 18 Jan 2019 Status changed from active, no longer recruiting to completed.
- 04 Sep 2015 Status changed from recruiting to active, no longer recruiting,as reported by University Hospital Medical Information Network - Japan.
- 08 Apr 2013 New trial record